Michelle Seitz's most recent trade in MSCI Inc was a trade of 385 Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MSCI Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 385 | 671 (0%) | 0% | 0 | Common Stock | |
MSCI Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 286 | 286 (0%) | 0% | 0 | Common Stock | |
Sana Biotechnology Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Sana Biotechnology Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
Sana Biotechnology Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Sana Biotechnology Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
Sana Biotechnology Inc | Michelle Seitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 11,795 | 11,795 | - | - | Stock Option (Right to Buy) |